In combination with melatonin at night, given with water, there was no reported impact on the action of the peptide
This assessment allows your aesthetician to determine the amount of product required, the number of sessions needed, the safest session interval, and the final cost of your treatment plan (if you choose to book a course of treatment)
Beyond their bioactivity, tripeptides exhibit physicochemical properties that enhance their suitability for therapeutic applications
(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement
Height Contenance 500 ml Fades dark spots, slows aging, and revives skins radiance